Ocala FL 脂肪性肝病临床试验
8项针对 脂肪性肝病的研究正在 Ocala及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
招募中3 期
- GSK Investigational Site, Ocala
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
招募中3 期
- GSK Investigational Site, Ocala
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
招募中3 期
- Akero Clinical Study Site, Ocala
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
招募中3 期
- GSK Investigational Site, Ocala
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
招募中2 期
- Ocala GI Research, Ocala
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
招募中3 期
- 89bio Clinical Study Site, Ocala
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
招募中3 期
- 89bio Clinical Study Site, Ocala
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
招募中3 期
- GSK Investigational Site, Ocala
其他城市的 脂肪性肝病试验
- San Antonio, TX17 项研究
- New York City, NY16 项研究
- Miami, FL16 项研究
- San Diego, CA14 项研究
- Houston, TX13 项研究
- Austin, TX13 项研究
- Richmond, VA12 项研究
- Chandler, AZ10 项研究
- Tucson, AZ10 项研究
- Orlando, FL9 项研究
- Hialeah, FL9 项研究
- St. Louis, MO9 项研究
Ocala的其他研究
- 非小细胞肺癌10 项研究
- 肥胖症7 项研究
- 阿尔茨海默病6 项研究
- 超重6 项研究
- 慢性阻塞性肺病5 项研究
- 心力衰竭5 项研究
- 轻度认知障碍3 项研究
- 转移性癌症3 项研究
- 动脉粥样硬化3 项研究
- 心血管疾病3 项研究
- 慢性疼痛3 项研究
- 肝脏疾病3 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。